Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Pariglasgene brecaparvovec by Ultragenyx Pharmaceutical for Glycogen Storage Disease 1A: Likelihood of Approval
Pariglasgene brecaparvovec is under clinical development by Ultragenyx Pharmaceutical and currently in Phase III for Glycogen Storage Disease 1A. According...